An undercover investigation by a Chinese media outlet, Upstream News, has uncovered a black market built around the country’s blood donation certificate system, where intermediaries recruit donors, arrange transactions, and resell official certificates for profit.
The investigation shows how a public health mechanism intended to encourage voluntary blood donation has evolved into a parallel market, with certificates traded across regions and used to secure access to hospital blood supplies.
China’s blood donation framework grants donors, as well as certain family members, access to discounted or priority blood transfusions. In practice, that entitlement has acquired tangible value, particularly in areas where blood supply remains limited.
In non-emergency situations, donors and their relatives may receive priority when demand exceeds supply. The policy has created conditions in which certificates can influence waiting times and treatment access, making them a target for resale.
Reporters from Upstream News documented how the system operates in practice. In one case, a middleman in Jiangsu province advertised paid “voluntary donation” opportunities through social media, offering cash compensation and transportation.
Success
You are now signed up for our newsletter
Success
Check your email to complete sign up
At a hospital in Shanghai, reporters found contact cards offering “mutual blood assistance” services. When they contacted a coordinator identified as Tang, she said a certificate could be arranged on the same day without requiring the patient’s family to meet the donor.
Tang quoted 2,000 yuan (about $275) for a 400-milliliter blood donation certificate and said multiple certificates could be arranged if needed. After a deposit was paid, a donor was reportedly sent to a blood center, and the certificate was delivered shortly afterward. The document was later confirmed to be authentic.
A black market supply chain
The investigation also examined how the supply chain functions. Middlemen recruit donors, often migrant workers, and pay them between 400 and 600 yuan for a standard donation. Certificates are then resold at higher prices, sometimes through multiple layers of intermediaries.
In Jiangsu, a broker surnamed Yang told reporters that even individuals who do not meet health requirements could still obtain certificates. He described a process in which payments are given to medical staff during screening procedures to avoid disqualification.
Yang said such practices had become routine and offered to arrange both donors and documentation. He also indicated that certificates could be sourced from multiple provinces, depending on demand.
Many of the recruited donors appeared to have limited understanding of how their donations were being used. One worker said he accepted the payment without knowing how the certificate would later be traded.
Medical personnel interviewed during the investigation suggested that verification procedures are not always strictly enforced. A doctor at a tertiary hospital said that in practice, hospitals focus on maintaining supply rather than confirming whether donors and recipients meet the formal relationship requirements.
The availability of certificates from different regions allows intermediaries to match supply with demand across provincial boundaries.
For patients’ families, the system presents practical challenges. Some reported difficulty organizing eligible donors within their social networks, particularly when medical conditions prevent participation. In those situations, purchasing a certificate becomes an alternative.
Online responses to the investigation reflected frustration among past donors. Some said they had expected their contributions to directly benefit patients, while others questioned the transparency of how donated blood is allocated.
China continues to face periodic shortages in its blood supply, especially in large urban centers. Demand for transfusions remains high, while voluntary donations have not consistently met clinical needs.
